Company Search:
Advanced Search
Sponsored Links
Poxel SA Company Snapshot
Poxel SA operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Poxel SA with three other companies in this sector in France: Innate Pharma S.A. (2018 sales of 79.89 million Euro [US$88.87 million] of which 100% was Licensing Revenue), Adocia SAS (47.39 million Euro [US$52.71 million] of which 100% was Regenerative Medicine), and Eurofins-Cerep SA (25.45 million Euro [US$28.31 million] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Poxel SA
  Stock Performance Chart for Poxel SA
  Stock Data: Recent Stock Performance:
  Current Price (1/10/2020): 12.84
(Figures in Euro)
1 Week -3.3%   13 Weeks 64.0%  
4 Weeks 62.5%   52 Weeks 142.3%  
Poxel SA Key Data:
  Ticker: POXEL Country: France
  Exchanges: PAR Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 74,605,000
(Year Ending Jan 2019).
Employees: 30
  Currency: Euro Market Cap: 332,745,737
  Fiscal Yr Ends: December Shares Outstanding: 25,914,777
  Share Type: Actions Ordinaires Closely Held Shares: 9,289,100
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.